Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alphatec Holdings (ATEC) Stock Price & Analysis

966 Followers

ATEC Stock Chart & Stats

$7.07$0.01(0.14%)
At close: 4:00 PM EST
$7.5$10Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$7.05 - $7.26
52-Week Range
$6.81 - $23.29
Previous Close
$7.06
Volume
N/A
Average Volume (3M)
4.62M
Market Cap
$1.14B
Enterprise Value
$2.16B
Total Cash (Recent Filing)
$79.94M
Total Debt (Recent Filing)
$593.95M
Price to Earnings (P/E)
―
Beta
0.65
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
0.12
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Surgeon Adoption And Procedure Growth

Rapid growth in procedure volumes and new surgeon adoption indicates that ATEC is expanding its clinical footprint and gaining platform acceptance. A broader surgeon base can support recurring implant demand, increase facility penetration, and create durable opportunities for cross-selling its technologies.

Margin And EBITDA Expansion

Strong EBITDA and gross-margin expansion shows improving operating leverage as revenue scales, while the margin profile benefits from cost control and product mix. If sustained, this progress can help ATEC fund innovation internally and move closer to durable bottom-line profitability.

Improved Liquidity And Capital Structure

Debt repayment and available liquidity strengthen financial flexibility during continued investment in inventory, instruments, and technology. A simpler capital structure reduces near-term refinancing pressure and gives ATEC more capacity to support surgeon growth and commercial expansion.

Bears Say

Revenue Pullback And Continuing Losses

The latest revenue contraction weakens confidence that prior growth can translate into a consistently expanding earnings base. Continued operating and net losses also indicate that ATEC has not yet proven durable profitability, leaving execution and scale benefits dependent on renewed demand.

Biologics And Revenue-per-Case Weakness

Lower biologics attachment rates reduce the value captured from each procedure and remove a historical source of annual growth. Persistent weakness in this component could limit mix improvement, pressure sales productivity, and make overall expansion more dependent on procedure volume.

Procedure-Market And Guidance Pressure

Reduced guidance reflects a less supportive procedure environment and weaker monetization than previously expected. Continued softness would make it harder for ATEC to convert surgeon adoption into revenue growth, while requiring tighter execution to deliver the targeted EBITDA and cash-flow outcomes.

Alphatec Holdings News

ATEC FAQ

What was Alphatec Holdings’s price range in the past 12 months?
Alphatec Holdings lowest stock price was $6.81 and its highest was $23.29 in the past 12 months.
What is Alphatec Holdings’s market cap?
Alphatec Holdings’s market cap is $1.14B.
When is Alphatec Holdings’s upcoming earnings report date?
Alphatec Holdings’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 108 days.
How were Alphatec Holdings’s earnings last quarter?
Alphatec Holdings released its earnings results on Oct 29, 2026. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.095 by -$0.005.
Is Alphatec Holdings overvalued?
According to Wall Street analysts Alphatec Holdings’s price is currently Undervalued.
Does Alphatec Holdings pay dividends?
Alphatec Holdings does not currently pay dividends.
What is Alphatec Holdings’s EPS estimate?
Alphatec Holdings’s EPS estimate is 0.12.
How many shares outstanding does Alphatec Holdings have?
Alphatec Holdings has 155,139,830 shares outstanding.
What happened to Alphatec Holdings’s price movement after its last earnings report?
Alphatec Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.095. Following the earnings report the stock price went down -38.083%.
Which hedge fund is a major shareholder of Alphatec Holdings?
Hedge funds hold Alphatec Holdings shares: the largest hedge-fund position in Alphatec Holdings is 71,883,912 shares, and hedge funds increased their holdings by 2.2M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology